OMEPRAZOLE AND THE INDUCTION OF HUMAN CYTOCHROME-P-450 - A RESPONSE TO CONCERNS ABOUT POTENTIAL ADVERSE-EFFECTS

被引：49

作者：

PARKINSON, A ^{[1
]}

HURWITZ, A ^{[1
]}

机构：

[1] UNIV KANSAS,MED CTR,DIV CLIN PHARMACOL,KANSAS CITY,KS 66103

来源：

GASTROENTEROLOGY | 1991年 / 100卷 / 04期

关键词：

D O I：

10.1016/0016-5085(91)90317-E

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1157 / 1164

页数：8

共 116 条

[1] ACETAMINOPHEN METABOLISM IN SUBJECTS FED CHARCOAL-BROILED BEEF [J].

ANDERSON, KE ;

SCHNEIDER, J ;

PANTUCK, EJ ;

PANTUCK, CB ;

MUDGE, GH ;

WELCH, RM ;

CONNEY, AH ;

KAPPAS, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (03) :369-374

[2]

ANDERSON LM, 1985, CANCER RES, V45, P6384

[3] EFFECT OF OMEPRAZOLE AND CIMETIDINE ON PLASMA DIAZEPAM LEVELS [J].

ANDERSSON, T ;

ANDREN, K ;

CEDERBERG, C ;

EDVARDSSON, G ;

HEGGELUND, A ;

LUNDBORG, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (01) :51-54

[4] EFFECT OF OMEPRAZOLE TREATMENT ON DIAZEPAM PLASMA-LEVELS IN SLOW VERSUS NORMAL RAPID METABOLIZERS OF OMEPRAZOLE [J].

ANDERSSON, T ;

CEDERBERG, C ;

EDVARDSSON, G ;

HEGGELUND, A ;

LUNDBORG, P .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :79-85

[5] SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS [J].

ANDERSSON, T ;

REGARDH, CG ;

DAHLPUUSTINEN, ML ;

BERTILSSON, L .

THERAPEUTIC DRUG MONITORING, 1990, 12 (04) :415-416

[6] 5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1 [J].

AOYAMA, T ;

YAMANO, S ;

GUZELIAN, PS ;

GELBOIN, HV ;

GONZALEZ, FJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4790-4793

[7]

ARCOS JC, 1961, J BIOL CHEM, V236, P1291

[8] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[9] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].

BERTILSSON, L ;

HENTHORN, TK ;

SANZ, E ;

TYBRING, G ;

SAWE, J ;

VILLEN, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355

[10] ACETAMINOPHEN HEPATOTOXICITY [J].

BLACK, M .

ANNUAL REVIEW OF MEDICINE, 1984, 35 :577-593

← 1 2 3 4 5 6 7 8 9 10 →